CDC42 and chronic myelogenous leukemia, BCR-ABL1 positive: Abnormal activities of TKs are closely associated with proliferation, invasion, metastasis, apoptosis, and tumor angiogenesis in non-small–cell lung cancer (NSCLC) [8], chronic myeloid leukemia (CML) [2,9], and many other tumors.